Serving the Community and Supporting Industry
The Research Centre for Reproductive Health focuses on research with a Clinical and Commercial Interface.
RCRH has generated intellectual property technology that is subject to licence or commercialisation. Some of the Centre's achievements include negotiating Consulting Contracts, Industry Research Grants, Industry Sponsored collaboration Research Agreements and a spin off company start up with Reproductive Health Sciences Pty Ltd.
RCRH has worked closely with Repromed and has active relationships with other clinical organisations to identify research needs and implement research findings. Researchers also have strong links and partnerships with companies in the human and animal assisted reproduction industry to develop novel therapeutics, devices and diagnostics.
RCRH has a number of senior researchers experienced in translation of research findings into biomedical applications.
RCRH members hold a number of patents that have helped to initiate partnerships with industry and create spin out companies.
Collaboration and Networks
Strong linkages and associations with other leading organisations in the area of developmental and reproductive health has allowed RCRH to:
- Enhance interdisciplinary links
- Provide viable connections between research and clinical needs
- Provide an interface between research and commercial interests
RCRH Research Commercialisation
Clinical and Health Benefits
|Jeremy Thompson & Robert Gilchrist||Development of bovine and human oocyte IVM media||IVF Procedure Efficiency||Cook Australia|
|Kelton Tremellen||OSMI Study Effect of novel anti-oxidant on sperm function||Roche Diagnostic & Repromed|
|Sarah Robertson||Method & Medium for In Vitro Fertilisation||IVF Procedure Efficiency||MediCult|
|David Kennaway||Licence agreement to market Melatonin Antibodies||Buhlmann Laboratories|
|Claire Roberts||IGF-II use in embryo culture media for ART||A media formulation to improve implantation rate, placental morphogenesis and pregnancy outcomes following IVF/ICSI||MediCult|
|Clarie Roberts||IGF-II as a therapeutic for use in women at risk of major pregnancy complications||Therapeutic to enhance placental morphogenesis and prevent or minimise pregnancy complications|